{"name":"NGM Biopharmaceuticals, Inc","slug":"ngm-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"ngmbio.com","description":"","hq":"South San Francisco","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NGM120","genericName":"NGM120","slug":"ngm120","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NGM120","genericName":"NGM120","slug":"ngm120","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOUjd6OXAzUm1tWjBESURQWS1KS0ZDbE9Jb0VzSnN2ZkJsbm95Q2NwRWZQck5FdDF0aThuYTZjVGowczZaRTM2Z2pqMkdsSkQ1eUhjTnAyakJaUElQVTRvYWlfelF5UnBISVAwMFlUa1lITC1jeU4tUV9MRzVTMFpQVU5GSEpoYkozWGxSSVlldGg1UzJpNFlzUFhPb0VwVjZFTEZz?oc=5","date":"2026-04-07","type":"pipeline","source":"TradingView","summary":"Book value per share of NGM Biopharmaceuticals, Inc. – GETTEX:0IK - TradingView","headline":"Book value per share of NGM Biopharmaceuticals, Inc. – GETTEX:0IK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNRGJvY2tPSTlMZGdEdWc5NEE0R0w4cG5ZTlZaZzdTUE10aF9hMW4xSlR4a0xib29SSHVleTBKSHM2ZzhwM05mTzZxZzdzMlEzYXJjbzJPemwySE9tM01aLWJtZC1xTjNqamRCSExpMnY1eHJvdVl0NUUya3ltbkV1YldYcVl1S0FrcXdVZHN0c0VSaGNvQ0JxcFZNMUJqMlZNR2ltZ1NjNFdlbi02U1Z1SA?oc=5","date":"2026-01-06","type":"pipeline","source":"BioSpace","summary":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer - BioSpace","headline":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNal9yb0poS19QYmQ1U3N3bGFzYXJ3VVFoNFZ1bFBEbWFTRGIwbmZOcVdqR0JaSWtsNjR1dVhjNzRaVFJLUzJBSDQtRUpha1VkNW9WSDdlY3pOd2FHeTRHXzhtUEZwMlJYSWFoWUhucWQ1eWdtTEkxNzR1MHlrSGpvUnBkZVE0ODlWQVpoRWhBS19iSUlXY3FsemVFd0xzV2RmOV91MUxSZ2NoWTFnNjFqQXF1QW83YzRTNDZlZ0FNYmZha1dGRjVNbzViMldQSXdyRXl6V1EtVmdRYlZOZHZuTnVQU2ZZR1NZQ0hqRmpuZkw1X09uRHMzd0duNlpOZlhULWMzRnVlajBBb3g0OWJYQnExeGNMc2ZqZHFuMld5YmFObkVMZFF0VXJLT3BpRVRFM3ZUS2Q4TGw4TDhLUUhGS1V4VU1kbS00Q0NR?oc=5","date":"2025-12-01","type":"pipeline","source":"GlobeNewswire","summary":"Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire","headline":"Geographic Atrophy Market to Surge Significantly During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBEckZnaE54anlRZXZTZDFBM2FZYzlYTEMxUTRDTmkxa1lVWkE4b25sd0ZuOUszSFhpS2JsRE5HVWZ3d3paVUpSbTIteEtCbW5vYUpGODlSbnp2QUFDbUIyTi1nWTI?oc=5","date":"2025-10-03","type":"pipeline","source":"R&D World","summary":"2025 R&D layoffs tracker: hardware and chips lead the year’s biggest cuts while biopharma pares pipelines - R&D World","headline":"2025 R&D layoffs tracker: hardware and chips lead the year’s biggest cuts while biopharma pares pipelines - R&D World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOX0tWV1VaVnlYcXVwVnNxa1o0cDZ6eHQwMDR6VUUzTE9UdlFPVVhKMkFxRTNDUTA4bWo5UnFid0hLaHh2bVpDaGJvbHFTakpsSTF4TUFTSEkwOF9EV215M0d6REs3clN6UHQwZ0Q2bWtxM3Y0VkhSRUxtYVoxbEFweUg3WnYweGNmenkyM21jeGNhcFpQcm1BOWxnNF9LeTNyaFNtZDRFWWFKRUNXbk1hMnFJYkZuWHl5Zk1fSERRcXBoWnpfVFBDR2M1dVNrXy1IMkdzcGFtdzdvWGdWSnY2M0tHWWo5WFVwVG9PZjRwWldZbWt6aFFHUVlVek0yWHBCZUV2UHpmcEI5N0syUXRyT1A2ckpOdmc?oc=5","date":"2025-08-07","type":"trial","source":"GlobeNewswire","summary":"Cancer Cachexia Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"Cancer Cachexia Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNa2hSUmtnQnJaYWU4cDZpcVgwUzhWWTZzdEtOMVJuVFlkSTl0VE1rSnNyZnUtZXNfVlJ5Xy1HTHF3d0FSYkIwV2xKWG9wM2FpWUJvRzJYS3V5ZXUzTU9mUUpuaFRIM0ZqeWVYUC1ER3BhYVljSmN0ZDRoeUR0RFB2Slg5Vkczek01WXB6YWJtRWQ3MzdQZFk3UVNWZDAyQXEweC1HQmFLRXBwbGRmam4wUFVHdlE5NGdtRUdEVmw2LTZmczA?oc=5","date":"2025-05-12","type":"pipeline","source":"Fierce Biotech","summary":"NGM Bio slims down in strategic pivot, cutting 75% of staff and halting a midstage liver disease program - Fierce Biotech","headline":"NGM Bio slims down in strategic pivot, cutting 75% of staff and halting a midstage liver disease program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9rRHV6dEI1WDJ1TGZIUE9hZjV5cW1Kakd6YU1TQkdlZHVtQjliLTlfS0VqTl9LUG1nUkJCZUN4S1hsN0RkbzRoOU11RnVSSWFkOC1EVkNnREdZZ0hnZGU0eUx6WmNTbHdrQzg1dmtSNzFJRko1OHh2bw?oc=5","date":"2024-12-19","type":"pipeline","source":"BioPharma Dive","summary":"A venture firm breathes new life into an old NGM drug - BioPharma Dive","headline":"A venture firm breathes new life into an old NGM drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNZDNBTGE0eTBhYjZaNXNSRkJHb2NxQjZCeGNIUTYwelRiZm1NS3hRZ2IxRlNseGJmWmpRMjRTM1Izb3U0Ui1HaHQ0ZnpvOUhPYzJTVFdNb2RoYTdsTDJ3b29WQjRod3NFbS1LTWRQOVg5T2FFR1N2ODNpMWx4ZThGR1hVX2NCWlUzVkZIYkhXSUtncU9Ob3pFYTJNWkNFS3p0ZWppdmJIVkVZQnBlWmQxQmwwY2l3NGRrYlpuOGo5anRsV0hKOTFGNDd5OE9MNkxWUHV4eTRJSWdpRE1senFVT0FlZmFNc1pncGFSRGstUWF4bk14X0lUMGxkdFhwM1dOdG9LSFBQYmt6Tm1najZZRzZPSUExakFvVnlDWTJGNDhFTkd6Y0tzdE9IVGZwZHFJUVJubg?oc=5","date":"2024-12-19","type":"deal","source":"GlobeNewswire","summary":"NGM Bio and KdT Ventures Enter into Worldwide License - GlobeNewswire","headline":"NGM Bio and KdT Ventures Enter into Worldwide License","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQZUxSN24tLV9FUE9XRGpnTm5IQThWeHZvN29WNWtIU2Q3R0ozYm9TUENMU3NqVUNGTEJWRFN6MjJERXBJcnROUHBhTmk1UUZkbnNjYVdGNzQwdUp3YW1zdUZLVnU0SnBpU0lNaTFtblpkWGNEWjBqRXhZbWoyNkR2Yl92cEJCdnNvUGpwXzVR?oc=5","date":"2024-07-17","type":"pipeline","source":"BioPharma Dive","summary":"NGM, now private, raises $122M for redrawn research plans - BioPharma Dive","headline":"NGM, now private, raises $122M for redrawn research plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOc0JQUUFPTWtDUUJ4NFVadlpGVklKZWhCN1RfUmVtZ3VnTlJsV19VbV9MMmw5NURnZGI3UTl5M0hyWDAxSGZPNkxpY3RaQVFmYThHRzduNWxuX0hnN1gwLXh2UV9rTmQ1Vjlya2hkcGtjZGhaRVlYcXE5T0JBTGszVER2Tlh2eGd1SXFZQ25yNmFzNG1Z?oc=5","date":"2024-02-26","type":"deal","source":"Fierce Biotech","summary":"NGM to go private as part of $135M buyout by VC firm Column Group - Fierce Biotech","headline":"NGM to go private as part of $135M buyout by VC firm Column Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZGxfbXh6RlJKUUsxWHcyZ295Zm83ekNMUFFfQTRndWgzeElQUERrdWltWXlXcEEzdWpad2oxcDhxbnhWdU1MNkVuR29fVjUwMW1DV05VSDcySExVNmttajhGZWZ6YzFWc0JqV0lBWmJwZThaclpEUkhNUGNaUC0yWFVPSk9GRTVZUkxEcEhCTEl5MjhBVHQ5XzI3Yzl3aEZHQVBiUDktVWdpMVE?oc=5","date":"2022-12-21","type":"pipeline","source":"MedCity News","summary":"Merck Sees No Future for NGM Bio’s Eye Drugs and Declines Licensing Options - MedCity News","headline":"Merck Sees No Future for NGM Bio’s Eye Drugs and Declines Licensing Options","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}